Go to the list of all blogs
Sarah Patel's Avatar
published in Blogs
Sep 19, 2023

Metabolic Group Dips: Analyzing $RYTM, $ARDX, $CBAY, $MDGL, $VKTX - Lose of -8.74%

📋 Introduction
A sweeping change has been observed in the metabolic sector this week, seeing an overall decline of -8.74%. Focusing on biotechnology companies that produce drugs to treat gastrointestinal and metabolism disorders, this sector is paramount for treating severe diseases linked to metabolic irregularities. Let's dissect the market movements, their influence on various sectors, and a deeper look into significant tickers that caught our attention.

🏭 Boost Your Trading Game in the Metabolic Group! 📈

If you're intrigued by the Metabolic group and its tickers, we've got the right AI tools to elevate your trading performance.

🔄 "Swing Trader: Business Model (TA&FA)" is your trusted companion for navigating these tickers with precision. Whether you're tracking trends or seeking to capitalize on business models, this AI strategy has you covered.

📊 Looking for growth opportunities? "Swing Trader, Long Only: Growth Model (Diversified)" is designed to optimize your trading decisions within a diversified portfolio, potentially enhancing your gains.

Unlock the doors to trading excellence within the Metabolic group with AI-backed precision! Embrace the opportunities, ride the trends, and potentially amplify your trading gains. Let our AI tools be your trusted companions on this exciting trading journey. 🚀📈  Discover the future of trading with AI expertise!

Tickers of this Group:


📈 Metabolic Sector Analysis: A Dive into Key Trends and Market Movements 📉

🔬 Industry Description

Biotechnology plays an essential role in the healthcare domain, particularly in concocting medicines to combat various diseases. Companies in this domain are always in a relentless pursuit of R&D to ensure the birth of innovative solutions. Key players such as Amgen Inc., Gilead Sciences, Inc., and Celgene Corporation signify the vitality of this industry.

💹 Market Cap

The metabolic sector showcases a broad spectrum in terms of market capitalization. On average, it stands at 1.4B, with MDGL taking the lead at a staggering 3.2B and ATXS sitting at the other end of the spectrum at 222.1M.

📊 High and Low Price Notable News

An intriguing movement to highlight is the average weekly price growth, which stands at -3.11%. Even more captivating is that, despite the weekly slump, the monthly and quarterly growth remains optimistic at 10.72% and 9.03% respectively. With stocks like ICPT growing by 1.87%, the downward trajectory of MDGL by -10.52% cannot be overlooked.

  • Spotlight: Rhythm Pharmaceuticals ($RYTM) witnessed a significant dip this week by -8.19%. Other notable mentions include Ardelyx ($ARDX) and CymaBay Therapeutics ($CBAY) which declined by -6.06% and -5.54% respectively.

🔉 Volume

The trading activity saw substantial growth in the metabolic sector. The average weekly volume surged by 166.18%. A remarkable record was set by Ardelyx with a daily growth that skyrocketed by 269% of its 65-Day Volume Moving Average.

📊 Fundamental Analysis Ratings

Ratings offer a sneak peek into the intrinsic health of the stocks:

  • Valuation Rating: 70
  • P/E Growth Rating: 92
  • Price Growth Rating: 46
  • SMR Rating: 98
  • Profit Risk Rating: 78
  • Seasonality Score: -46

🌟 Notable Companies

This sector houses industry titans such as:

  • Regeneron Pharmaceuticals ($REGN)
  • Moderna ($MRNA)
  • Incyte Corp ($INCY)

💡 Ticker Descriptions

  1. CymaBay Therapeutics ($CBAY): Recently broke above its upper Bollinger Band, a sign of a potential decline. With a current price of $15.95 and a prior month uptrend of +29%, the ticker demands close attention.

  2. MDGL: Recent technical signals suggest a potential long-term bearish trend with its 50-day MA crossing below the 200-day MA. Its current price stands at $163.58, with a monthly uptrend of +0.99%.

  3. Rhythm Pharmaceuticals ($RYTM): The 10-day RSI indicates a potential shift to a downward trend, signaling a selling sentiment among traders.

  4. VKTX: The Stochastic Indicator suggests a potential bearish stance, supported by A.I. analysis indicating an 87% chance of a downward move.

  5. Ardelyx ($ARDX): Similar to RYTM, its 10-day RSI suggests a downturn, pushing a 88% likelihood of a further decrease in its price.

The metabolic sector, despite its recent challenges, remains a vital cog in the biotech industry. While the sector experienced a decline this week, it's essential to remember that stock movements are an intricate blend of multiple factors. As always, individual research complemented with professional advice is the key to navigating these choppy waters.



Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Sarepta Therapeutics (NASDAQ:SRPT), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), BioCryst Pharmaceuticals (NASDAQ:BCRX), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Novavax (NASDAQ:NVAX), Sorrento Therapeutics, Inc. (OTC:SRNEQ).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.22B. The market cap for tickers in the group ranges from 402 to 424.75B. NVO holds the highest valuation in this group at 424.75B. The lowest valued company is PNEXF at 402.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -4%. For the same Industry, the average monthly price growth was 27%, and the average quarterly price growth was 32%. BXPHF experienced the highest price growth at 300%, while SEEL experienced the biggest fall at -67%.


The average weekly volume growth across all stocks in the Biotechnology Industry was -44%. For the same stocks of the Industry, the average monthly volume growth was 29% and the average quarterly volume growth was 43%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 86
Price Growth Rating: 63
SMR Rating: 93
Profit Risk Rating: 95
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics for the treatment of chronic fibrotic and metabolic diseases

Industry Biotechnology

Pharmaceuticals Other
305 Madison Avenue
+1 646 747-1000
Interesting Tickers
1 Day
MFs / NAMEPrice $Chg $Chg %
Invesco Global Real Estate Income A
Goldman Sachs Intl Eq Insghts Instl
Franklin Global Market Neutral A
PGIM Jennison Focused Value A
Invesco Global Y

ICPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICPT has been loosely correlated with MORF. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ICPT jumps, then MORF could also see price increases.

Ticker /
1D Price
Change %
Loosely correlated
Loosely correlated
Loosely correlated
Loosely correlated
Loosely correlated
Artificial intelligence (AI) technology is developing rapidly.Data mining can deliver raw numbers, but it does not necessarily provide actionable insights. Structure is necessary to taking abstract information and extracting commonalities, like averages, ratios, and percentages.
You have enough faith in that stock, based on research, that the return will equal or exceed the investment.  Do unto others.The principles outlined here will ensure that happens.  Principle #1: Diversification Investors can’t be one-dimensional when constructing a portfolio.
Some of the world’s biggest financial institutions have devoted multi-million dollar budgets to developing algorithms that can find patterns in the market, identify trends, and perform automated trading designed to take advantage of even the smallest price movements. The AI revolution is so big that as it stands today, the world’s five biggest hedge funds all use systems-based approaches to trade financial markets.Indeed, quantitative trading hedge funds now manage $918 billion (according to HFR), which amounts to 30% of the $3 trillion hedge fund industry – a percentage continues to grow with each year that passes.
Where smaller, more volatile companies can placate shareholders with higher returns, larger companies often use dividend payouts to entice new investors and hold their existing ones. These low-risk options may not work for every investment approach, but dividend-producing stocks can offer great benefits under the right circumstances – especially for portfolios built for the long-term.Beyond the ability to rely on these semi-regular payouts as an income stream – a strategy favored by retirees – dividends are an excellent vehicle for compounding earnings through reinvestment.
Artificial intelligence (AI) and fintech have an inherent compatibility that has become clearer as each sector has matured, with recent growth and successes on their own accord bringing new ideas about how they can work together.AI can analyze information at far greater quantities (and far more quickly) than any human, making it a natural fit to help fintech firms streamline and automate processes that benefit customers and businesses alike. Fintech has brought a revolution of convenience to the finance world.
You’ve set up your bitcoin wallet and have acquired some bitcoins, and now you’re ready to use them – what’s next?But be VERY careful to double- or triple-check that the address is correct – crypto transactions are irreversible, and a typo almost certainly means permanently losing the bitcoins you were trying to send. One way to avoid potential slip-ups is to scan a QR code (when available) for the destination address.
Mainstream acceptance has come in fits and starts, with regulatory approval proving hard to come by for a variety of reasons – not least of which the ever-present risk of theft via hacking or other means, which pose an especially large obstacle to attracting investment from mainstream institutions. Because crypto holdings are only accessible via a specific private key, they are susceptible to loss – literally, if the key is written on a piece of paper or a physical hard drive, methods of offline ‘cold storage’ – or through hacks if held in an online wallet.Reuters reports that over $800 million in crypto assets were stolen in the first half of 2018, creating justifiable concern for both owners and mainstream financial institutions alike. Some type of insurance coverage would potentially mitigate the risks inherent to owning crypto assets – if insurers are willing to play ball.
Don't fall prey to common financial traps that can derail your financial planning efforts. In this article, we highlight four traps to keep in mind, including the importance of refinancing rather than consolidating student loans and credit card debt, prioritizing debt repayment over investments, limiting news consumption, and understanding the true costs of buying a home. Learn how AI tools from Tickeron can help investors make informed decisions and achieve their investment objectives.
Paper wallets are extremely useful tools – beyond being one of the most popular and secure cold storage methods, they make it simple to transfer coins between owners.You can access the funds on your paper wallet by “sweeping” (or importing) them to either a live wallet (like Trezor or Exodus) or an exchange service (like Coinbase). Most services allow you to import them directly from your wallet’s private key, but there are two key exceptions.
Get ready to revolutionize your investment strategy! Discover 3 cutting-edge ways to get fresh and innovative investment ideas, and say goodbye to relying on unreliable sources like CNBC. From utilizing advanced AI tools to sharing your portfolio with trusted friends, these methods are sure to boost your investment game. So, what are you waiting for? Read on to find out how you can start generating new ideas today!
You’re a trader, not an investor. It’s important that you understand the difference before choosing an actual trading style. Traders perform their magic over shorter periods of time, sometimes within minutes or hours. Investors are more passive. They purchase equities and hold them for months or years, relying on a long-term return. Traders evaluate buys and sells based on technical analysis...
Looking to invest your money in the stock market? While leaving your money there for a few years can yield a ten percent return, real traders know that actively trading and using derivatives is the way to make a significant profit while minimizing risk. Derivatives are contracts between two parties that are based on the price of a financial asset, such as a stock or bond. The value of the...
Zoom (ZOM), the video conferencing giant, registered a three-day uptrend of +1.84%. Our proprietary AI trading bot identified an intraday gain of 6.75%, attributing it to robust market sentiment and promising growth indicators. This uptrend signals a potentially strong position for investors and stakeholders. A deeper analysis could provide crucial insights into the future performance of ZOM. Stay updated for further analytics and forecast from our AI tools.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a remarkable performer. Operating within our robot factory, this trading algorithm has recently demonstrated its prowess by generating a notable gain of 3.74% while trading ZIM (ZIM Integrated Shipping Services Ltd) over the previous week. This article aims to delve into the technical analysis surrounding ZIM's recent performance and the potential for an impending price rebound.
AI trading robot, the Swing trader: Volatility Balanced Strategy (TA), has stood out as a performer in our robot factory. In the previous week, it achieved an impressive 3.78% gain while trading AFRM (Affirm Holdings Inc.), a notable stock in the market. In this article, we will delve into the technical analysis of AFRM's recent movements and explore the implications of its earnings results.
Among them, the Swing Trader: Volatility Balanced Strategy (TA) stands out as a top-performing AI trading robot. In the previous week, this robot demonstrated its prowess by generating an impressive 3.60% gain while trading NET (stock ticker symbol) – a remarkable achievement. This article delves into the reasons behind the success of Swing Trader, focusing on the positive Moving Average Convergence Divergence (MACD) indicator and the recent earning results of NET.
The Swing Trader: Volatility Balanced Strategy (TA), has caught our attention for its impressive performance. Last week, it generated a remarkable gain of 3.56% while trading RIOT, a prominent stock. In this article, we will delve into the analysis of RIOT's recent bearish trend and examine the company's earnings results, which exceeded expectations.
The Swing Trader: Volatility Balanced Strategy (TA) AI trading robot has emerged as a top performer in our robot factory, demonstrating exceptional performance and generating significant gains. In the previous week, this intelligent trading bot achieved a remarkable 3.56% gain while trading WKHS (Workhorse Group Inc.) - an achievement worth noting. Coupled with positive market indicators, WKHS presents an intriguing opportunity for potential future growth.
AI trading robot, known as "Swing trader: Volatility Balanced Strategy (TA)," has caught the attention of traders and investors alike. In the previous week, this AI robot, developed in our esteemed robot factory, demonstrated impressive performance by generating a gain of 3.51% while trading DKNG. This article will delve into the recent trading activity, the significance of the stock's upward trend, and analyze the latest earnings results of DKNG.
One such tool that has garnered attention is the AI trading robot known as Swing trader: Volatility Balanced Strategy (TA). This robot, developed in our esteemed factory, recently demonstrated its prowess by generating a notable 3.02% gain while trading CHPT (ChargePoint Holdings) over the previous week. While CHPT experienced a downward trend, the robot's performance and insightful analysis provide valuable insights for traders and investors alike.